Morillas, Rodelyn A.
HRN: 23-93-93 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2023
CEFUROXIME 750MG (VIAL)
10/20/2023
10/26/2023
IVT
280mg
Q8
URTI
Checking Final Appropriateness